HEADER TRANSFERASE/ANTIBIOTIC 04-FEB-15 5AH4 TITLE THE SLIDING CLAMP OF MYCOBACTERIUM SMEGMATIS IN COMPLEX WITH A NATURAL TITLE 2 PRODUCT. COMPND MOL_ID: 1; COMPND 2 MOLECULE: DNA POLYMERASE III SUBUNIT BETA; COMPND 3 CHAIN: A, B; COMPND 4 EC: 2.7.7.7; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: CYCLOHEXYL GRISELIMYCIN; COMPND 8 CHAIN: C, D; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM SMEGMATIS; SOURCE 3 ORGANISM_TAXID: 1772; SOURCE 4 STRAIN: MC(2)155; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PVP008_DNANMSM; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES; SOURCE 12 ORGANISM_SCIENTIFIC: STREPTOMYCES CAELICUS; SOURCE 13 ORGANISM_TAXID: 1520516 KEYWDS TRANSFERASE-ANTIBIOTIC COMPLEX, DNAN, DNA POLYMERASE, TUBERCULOSIS EXPDTA X-RAY DIFFRACTION AUTHOR P.LUKAT,A.KLING,D.W.HEINZ,R.MUELLER REVDAT 4 10-JAN-24 5AH4 1 REMARK LINK ATOM REVDAT 3 24-APR-19 5AH4 1 SEQRES LINK REVDAT 2 17-JUN-15 5AH4 1 JRNL REVDAT 1 03-JUN-15 5AH4 0 JRNL AUTH A.KLING,P.LUKAT,D.V.ALMEIDA,A.BAUER,E.FONTAINE,S.SORDELLO, JRNL AUTH 2 N.ZABURANNYI,J.HERRMANN,S.C.WENZEL,C.KONIG,N.C.AMMERMAN, JRNL AUTH 3 M.B.BARRIO,K.BORCHERS,F.BORDON-PALLIER,M.BRONSTRUP, JRNL AUTH 4 G.COURTEMANCHE,M.GERLITZ,M.GESLIN,P.HAMMANN,D.W.HEINZ, JRNL AUTH 5 H.HOFFMANN,S.KLIEBER,M.KOHLMANN,M.KURZ,C.LAIR,H.MATTER, JRNL AUTH 6 E.NUERMBERGER,S.TYAGI,L.FRAISSE,J.H.GROSSET,S.LAGRANGE, JRNL AUTH 7 R.MULLER JRNL TITL ANTIBIOTICS. TARGETING DNAN FOR TUBERCULOSIS THERAPY USING JRNL TITL 2 NOVEL GRISELIMYCINS. JRNL REF SCIENCE V. 348 1106 2015 JRNL REFN ISSN 0036-8075 JRNL PMID 26045430 JRNL DOI 10.1126/SCIENCE.AAA4690 REMARK 2 REMARK 2 RESOLUTION. 2.31 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.31 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 76.27 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 47824 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.176 REMARK 3 R VALUE (WORKING SET) : 0.173 REMARK 3 FREE R VALUE : 0.223 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2417 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 76.3122 - 5.9453 1.00 2746 150 0.1499 0.1914 REMARK 3 2 5.9453 - 4.7191 1.00 2697 140 0.1415 0.1919 REMARK 3 3 4.7191 - 4.1227 1.00 2684 152 0.1303 0.1658 REMARK 3 4 4.1227 - 3.7457 1.00 2656 161 0.1611 0.2014 REMARK 3 5 3.7457 - 3.4773 1.00 2668 155 0.1836 0.2630 REMARK 3 6 3.4773 - 3.2722 1.00 2727 118 0.1954 0.2576 REMARK 3 7 3.2722 - 3.1084 1.00 2624 134 0.1960 0.2303 REMARK 3 8 3.1084 - 2.9731 1.00 2683 143 0.2013 0.2664 REMARK 3 9 2.9731 - 2.8586 1.00 2682 151 0.1984 0.2640 REMARK 3 10 2.8586 - 2.7599 1.00 2672 137 0.2014 0.2949 REMARK 3 11 2.7599 - 2.6736 1.00 2663 115 0.1958 0.2211 REMARK 3 12 2.6736 - 2.5972 1.00 2680 135 0.2026 0.2732 REMARK 3 13 2.5972 - 2.5288 1.00 2660 140 0.2153 0.2453 REMARK 3 14 2.5288 - 2.4671 1.00 2659 140 0.2170 0.2972 REMARK 3 15 2.4671 - 2.4110 1.00 2639 157 0.2230 0.2655 REMARK 3 16 2.4110 - 2.3597 1.00 2624 165 0.2323 0.2924 REMARK 3 17 2.3597 - 2.3125 1.00 2643 124 0.2495 0.3001 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.270 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.000 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 47.59 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 62.83 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 5897 REMARK 3 ANGLE : 1.173 8063 REMARK 3 CHIRALITY : 0.046 989 REMARK 3 PLANARITY : 0.005 1057 REMARK 3 DIHEDRAL : 16.241 2176 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 6 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 9 THROUGH 132 ) REMARK 3 ORIGIN FOR THE GROUP (A): 115.9250 -16.1312 59.7443 REMARK 3 T TENSOR REMARK 3 T11: 1.0184 T22: 0.5911 REMARK 3 T33: 0.5817 T12: -0.2364 REMARK 3 T13: -0.1182 T23: -0.0352 REMARK 3 L TENSOR REMARK 3 L11: 0.9458 L22: 3.6104 REMARK 3 L33: 4.4030 L12: -0.0319 REMARK 3 L13: -0.7868 L23: -2.8655 REMARK 3 S TENSOR REMARK 3 S11: -0.3379 S12: 0.1286 S13: -0.0203 REMARK 3 S21: -1.0441 S22: 0.1997 S23: 0.2917 REMARK 3 S31: 1.2607 S32: -0.2949 S33: 0.1518 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 133 THROUGH 268 ) REMARK 3 ORIGIN FOR THE GROUP (A): 119.3586 -21.7819 89.5384 REMARK 3 T TENSOR REMARK 3 T11: 0.6058 T22: 0.3244 REMARK 3 T33: 0.4683 T12: -0.0222 REMARK 3 T13: 0.1071 T23: -0.0231 REMARK 3 L TENSOR REMARK 3 L11: 1.2227 L22: 1.8473 REMARK 3 L33: 5.2265 L12: -0.1977 REMARK 3 L13: 0.6868 L23: 0.9694 REMARK 3 S TENSOR REMARK 3 S11: -0.0300 S12: 0.2286 S13: -0.3220 REMARK 3 S21: -0.1287 S22: -0.1427 S23: 0.0785 REMARK 3 S31: 1.0549 S32: -0.2993 S33: 0.1189 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 269 THROUGH 396 ) REMARK 3 ORIGIN FOR THE GROUP (A): 118.6980 -0.8128 107.1386 REMARK 3 T TENSOR REMARK 3 T11: 0.2516 T22: 0.2726 REMARK 3 T33: 0.4014 T12: 0.0003 REMARK 3 T13: 0.0433 T23: 0.0381 REMARK 3 L TENSOR REMARK 3 L11: 1.1160 L22: 5.9167 REMARK 3 L33: 4.3798 L12: -0.5914 REMARK 3 L13: -0.3908 L23: -0.3820 REMARK 3 S TENSOR REMARK 3 S11: 0.1704 S12: -0.0298 S13: 0.2952 REMARK 3 S21: 0.2634 S22: -0.2039 S23: -0.0298 REMARK 3 S31: -0.2367 S32: -0.1092 S33: 0.0125 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: CHAIN 'B' AND (RESID 9 THROUGH 117 ) REMARK 3 ORIGIN FOR THE GROUP (A): 156.4281 -20.4092 56.1175 REMARK 3 T TENSOR REMARK 3 T11: 0.3502 T22: 0.2481 REMARK 3 T33: 0.3533 T12: -0.0058 REMARK 3 T13: 0.0413 T23: 0.0112 REMARK 3 L TENSOR REMARK 3 L11: 4.0186 L22: 6.1210 REMARK 3 L33: 5.4517 L12: 0.7570 REMARK 3 L13: 0.1180 L23: 1.5414 REMARK 3 S TENSOR REMARK 3 S11: 0.1260 S12: -0.1961 S13: 0.0082 REMARK 3 S21: 0.2732 S22: -0.2707 S23: 0.1354 REMARK 3 S31: -0.4366 S32: -0.2024 S33: 0.1246 REMARK 3 TLS GROUP : 5 REMARK 3 SELECTION: CHAIN 'B' AND (RESID 118 THROUGH 268 ) REMARK 3 ORIGIN FOR THE GROUP (A): 155.7866 -13.4487 84.3012 REMARK 3 T TENSOR REMARK 3 T11: 0.6153 T22: 0.5450 REMARK 3 T33: 0.3793 T12: -0.1208 REMARK 3 T13: 0.0313 T23: -0.0930 REMARK 3 L TENSOR REMARK 3 L11: 0.6799 L22: 1.8272 REMARK 3 L33: 6.3308 L12: -0.9763 REMARK 3 L13: 0.5736 L23: -1.6885 REMARK 3 S TENSOR REMARK 3 S11: 0.1342 S12: 0.0640 S13: 0.1528 REMARK 3 S21: 0.0090 S22: -0.1128 S23: -0.1147 REMARK 3 S31: -1.2991 S32: 0.7115 S33: -0.0378 REMARK 3 TLS GROUP : 6 REMARK 3 SELECTION: CHAIN 'B' AND (RESID 269 THROUGH 396 ) REMARK 3 ORIGIN FOR THE GROUP (A): 160.6463 -34.7883 103.9484 REMARK 3 T TENSOR REMARK 3 T11: 0.2970 T22: 0.6835 REMARK 3 T33: 0.3953 T12: 0.0727 REMARK 3 T13: -0.0937 T23: -0.0739 REMARK 3 L TENSOR REMARK 3 L11: 2.1490 L22: 4.4701 REMARK 3 L33: 4.4289 L12: -0.6524 REMARK 3 L13: -0.0781 L23: -0.1351 REMARK 3 S TENSOR REMARK 3 S11: 0.2288 S12: -0.0844 S13: -0.3172 REMARK 3 S21: 0.1674 S22: -0.1239 S23: -0.1118 REMARK 3 S31: 0.4205 S32: 0.7749 S33: -0.1079 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: WEAKLY DEFINED RESIDUES WERE MODELLED REMARK 3 AS ALANINES. REMARK 4 REMARK 4 5AH4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-FEB-15. REMARK 100 THE DEPOSITION ID IS D_1290062963. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-AUG-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06DA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : BARTELS MONOCHROMATOR WITH DUAL REMARK 200 CHANNEL CUT CRYSTALS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 47835 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.310 REMARK 200 RESOLUTION RANGE LOW (A) : 76.270 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 7.000 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.31 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.20 REMARK 200 R MERGE FOR SHELL (I) : 0.86000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3P16 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.10 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.08 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 200 MM MGCL2 16.3 % (V/V) GLYCEROL REMARK 280 12.2 % (W/V) PEG 3350 100 MM TRIS-HCL PH 7.44, PH 7.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 75.94400 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 48.06200 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 75.94400 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 48.06200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5660 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 34560 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -40.7 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 275.43215 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 48.06200 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 152.25155 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5660 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 34560 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -40.7 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 275.43215 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 -48.06200 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 152.25155 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B2094 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 NOVEL SYNTHETIC ANALOG OF NATURAL PRODUCT GRISELIMYCIN REMARK 400 REMARK 400 THE CYCLOHEXYL-GRISELIMYCIN IS PEPTIDE-LIKE, A MEMBER OF ANTIBIOTIC REMARK 400 CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: CYCLOHEXYL-GRISELIMYCIN REMARK 400 CHAIN: C, D REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -3 REMARK 465 GLY A -2 REMARK 465 GLY A -1 REMARK 465 ARG A 0 REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 THR A 3 REMARK 465 THR A 4 REMARK 465 THR A 5 REMARK 465 ALA A 6 REMARK 465 GLY A 7 REMARK 465 LEU A 8 REMARK 465 PRO A 35 REMARK 465 THR A 36 REMARK 465 ILE A 37 REMARK 465 PRO A 38 REMARK 465 GLY A 216 REMARK 465 THR A 217 REMARK 465 ASP A 218 REMARK 465 ASN A 373 REMARK 465 GLY A 397 REMARK 465 GLY B -3 REMARK 465 GLY B -2 REMARK 465 GLY B -1 REMARK 465 ARG B 0 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 THR B 3 REMARK 465 THR B 4 REMARK 465 THR B 5 REMARK 465 ALA B 6 REMARK 465 GLY B 7 REMARK 465 LEU B 8 REMARK 465 PRO B 35 REMARK 465 THR B 36 REMARK 465 ASP B 218 REMARK 465 GLY B 219 REMARK 465 ASP B 370 REMARK 465 GLY B 371 REMARK 465 ALA B 372 REMARK 465 ASN B 373 REMARK 465 GLY B 397 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 34 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 122 CG CD OE1 OE2 REMARK 470 ASP A 123 CG OD1 OD2 REMARK 470 GLU A 132 CG CD OE1 OE2 REMARK 470 LYS A 234 CG CD CE NZ REMARK 470 LYS A 383 CG CD CE NZ REMARK 470 ARG B 34 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 132 CG CD OE1 OE2 REMARK 470 THR B 217 OG1 CG2 REMARK 470 LYS B 234 CG CD CE NZ REMARK 470 LYS B 383 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER A 170 OE1 GLU A 199 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH B 2093 O HOH B 2093 2858 1.44 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 30 55.61 -105.54 REMARK 500 THR A 48 -153.71 -121.82 REMARK 500 ASP A 58 24.91 -143.44 REMARK 500 TYR A 59 -18.96 79.01 REMARK 500 GLU A 70 90.26 -67.02 REMARK 500 SER A 73 124.62 -172.10 REMARK 500 LEU A 159 72.23 -119.42 REMARK 500 ARG A 181 -14.87 83.67 REMARK 500 ASN A 220 -83.59 -59.43 REMARK 500 ASP A 301 -113.54 59.82 REMARK 500 THR A 355 -100.10 -118.20 REMARK 500 THR B 48 -169.65 -115.44 REMARK 500 THR B 48 -169.48 -115.44 REMARK 500 ASP B 58 21.46 -142.10 REMARK 500 TYR B 59 -27.49 83.21 REMARK 500 ARG B 181 -9.06 88.71 REMARK 500 ALA B 195 -150.55 -81.75 REMARK 500 GLU B 243 103.68 -59.88 REMARK 500 ASP B 253 31.01 -91.20 REMARK 500 SER B 300 126.98 -172.16 REMARK 500 ASP B 301 -112.60 62.06 REMARK 500 THR B 355 -88.13 -124.38 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 CYCLOHEXYLGRISELIMYCIN IS A SYNTHETICALLY GENERATED DERIVATIVE REMARK 600 OF THE NATURAL PRODUCT GRISELIMYCIN FROM STREPTOMYCES CAELICUS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A1398 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU A 327 O REMARK 620 2 PRO A 328 O 61.4 REMARK 620 3 HOH A2058 O 134.5 73.4 REMARK 620 N 1 2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA A 1398 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF CYCLOHEXYL REMARK 800 GRISELIMYCIN REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D OF CYCLOHEXYL REMARK 800 GRISELIMYCIN REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5AGU RELATED DB: PDB REMARK 900 THE SLIDING CLAMP OF MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH A REMARK 900 NATURAL PRODUCT. REMARK 900 RELATED ID: 5AGV RELATED DB: PDB REMARK 900 THE SLIDING CLAMP OF MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH A REMARK 900 NATURAL PRODUCT. REMARK 900 RELATED ID: 5AH2 RELATED DB: PDB REMARK 900 THE SLIDING CLAMP OF MYCOBACTERIUM SMEGMATIS IN COMPLEX WITH A REMARK 900 NATURAL PRODUCT. REMARK 999 REMARK 999 SEQUENCE REMARK 999 FIRST 4 N-TERMINAL RESIDUES REMAINED FROM THE TEV SITE REMARK 999 AFTER PROTEOLYTIC CLEAVAGE DBREF 5AH4 A 1 397 UNP A0QND6 A0QND6_MYCS2 1 397 DBREF 5AH4 B 1 397 UNP A0QND6 A0QND6_MYCS2 1 397 DBREF 5AH4 C 1 11 PDB 5AH4 5AH4 1 11 DBREF 5AH4 D 1 11 PDB 5AH4 5AH4 1 11 SEQADV 5AH4 GLY A -3 UNP A0QND6 EXPRESSION TAG SEQADV 5AH4 GLY A -2 UNP A0QND6 EXPRESSION TAG SEQADV 5AH4 GLY A -1 UNP A0QND6 EXPRESSION TAG SEQADV 5AH4 ARG A 0 UNP A0QND6 EXPRESSION TAG SEQADV 5AH4 GLY B -3 UNP A0QND6 EXPRESSION TAG SEQADV 5AH4 GLY B -2 UNP A0QND6 EXPRESSION TAG SEQADV 5AH4 GLY B -1 UNP A0QND6 EXPRESSION TAG SEQADV 5AH4 ARG B 0 UNP A0QND6 EXPRESSION TAG SEQRES 1 A 401 GLY GLY GLY ARG MET ALA THR THR THR ALA GLY LEU THR SEQRES 2 A 401 ASP LEU LYS PHE ARG VAL VAL ARG GLU ASP PHE ALA ASP SEQRES 3 A 401 ALA VAL ALA TRP VAL ALA ARG SER LEU PRO THR ARG PRO SEQRES 4 A 401 THR ILE PRO VAL LEU ALA GLY VAL LEU LEU THR GLY THR SEQRES 5 A 401 ASP GLU GLY LEU THR ILE SER GLY PHE ASP TYR GLU VAL SEQRES 6 A 401 SER ALA GLU VAL LYS VAL SER ALA GLU ILE ALA SER ALA SEQRES 7 A 401 GLY SER VAL LEU VAL SER GLY ARG LEU LEU SER ASP ILE SEQRES 8 A 401 THR LYS ALA LEU PRO ALA LYS PRO VAL GLU VAL SER VAL SEQRES 9 A 401 GLU GLY THR ARG VAL SER LEU THR CYS GLY SER ALA ARG SEQRES 10 A 401 PHE SER LEU PRO THR LEU ALA VAL GLU ASP TYR PRO ALA SEQRES 11 A 401 LEU PRO ALA LEU PRO GLU GLU THR GLY VAL ILE ALA SER SEQRES 12 A 401 ASP LEU PHE ALA GLU ALA ILE GLY GLN VAL ALA VAL ALA SEQRES 13 A 401 ALA GLY ARG ASP ASP THR LEU PRO MET LEU THR GLY ILE SEQRES 14 A 401 ARG VAL GLU ILE SER GLY GLU SER VAL VAL LEU ALA ALA SEQRES 15 A 401 THR ASP ARG PHE ARG LEU ALA VAL ARG GLU LEU THR TRP SEQRES 16 A 401 VAL THR THR ALA GLY ASP VAL GLU ALA ALA VAL LEU VAL SEQRES 17 A 401 PRO ALA LYS THR LEU ALA GLU ALA ALA LYS ALA GLY THR SEQRES 18 A 401 ASP GLY ASN GLN VAL HIS LEU ALA LEU GLY SER GLY ALA SEQRES 19 A 401 SER VAL GLY LYS ASP GLY LEU LEU GLY ILE ARG SER GLU SEQRES 20 A 401 GLY LYS ARG SER THR THR ARG LEU LEU ASP ALA GLU PHE SEQRES 21 A 401 PRO LYS PHE ARG GLN LEU LEU PRO ALA GLU HIS THR ALA SEQRES 22 A 401 VAL ALA THR ILE GLY VAL ALA GLU LEU THR GLU ALA ILE SEQRES 23 A 401 LYS ARG VAL ALA LEU VAL ALA ASP ARG GLY ALA GLN ILE SEQRES 24 A 401 ARG MET GLU PHE SER ASP ASP THR LEU LYS LEU SER ALA SEQRES 25 A 401 GLY ALA ASP ASP VAL GLY ARG ALA GLU GLU ASP LEU PRO SEQRES 26 A 401 VAL ASP PHE ALA GLY GLU PRO LEU THR ILE ALA PHE ASN SEQRES 27 A 401 PRO THR TYR LEU THR ASP GLY LEU GLY SER LEU HIS SER SEQRES 28 A 401 GLU ARG VAL THR PHE GLY PHE THR THR PRO SER ARG PRO SEQRES 29 A 401 ALA VAL LEU ARG PRO ALA GLY GLU ASP ASP GLY ALA ASN SEQRES 30 A 401 GLY GLY SER GLY PRO PHE PRO ALA ALA LYS THR ASP TYR SEQRES 31 A 401 VAL TYR LEU LEU MET PRO VAL ARG LEU PRO GLY SEQRES 1 B 401 GLY GLY GLY ARG MET ALA THR THR THR ALA GLY LEU THR SEQRES 2 B 401 ASP LEU LYS PHE ARG VAL VAL ARG GLU ASP PHE ALA ASP SEQRES 3 B 401 ALA VAL ALA TRP VAL ALA ARG SER LEU PRO THR ARG PRO SEQRES 4 B 401 THR ILE PRO VAL LEU ALA GLY VAL LEU LEU THR GLY THR SEQRES 5 B 401 ASP GLU GLY LEU THR ILE SER GLY PHE ASP TYR GLU VAL SEQRES 6 B 401 SER ALA GLU VAL LYS VAL SER ALA GLU ILE ALA SER ALA SEQRES 7 B 401 GLY SER VAL LEU VAL SER GLY ARG LEU LEU SER ASP ILE SEQRES 8 B 401 THR LYS ALA LEU PRO ALA LYS PRO VAL GLU VAL SER VAL SEQRES 9 B 401 GLU GLY THR ARG VAL SER LEU THR CYS GLY SER ALA ARG SEQRES 10 B 401 PHE SER LEU PRO THR LEU ALA VAL GLU ASP TYR PRO ALA SEQRES 11 B 401 LEU PRO ALA LEU PRO GLU GLU THR GLY VAL ILE ALA SER SEQRES 12 B 401 ASP LEU PHE ALA GLU ALA ILE GLY GLN VAL ALA VAL ALA SEQRES 13 B 401 ALA GLY ARG ASP ASP THR LEU PRO MET LEU THR GLY ILE SEQRES 14 B 401 ARG VAL GLU ILE SER GLY GLU SER VAL VAL LEU ALA ALA SEQRES 15 B 401 THR ASP ARG PHE ARG LEU ALA VAL ARG GLU LEU THR TRP SEQRES 16 B 401 VAL THR THR ALA GLY ASP VAL GLU ALA ALA VAL LEU VAL SEQRES 17 B 401 PRO ALA LYS THR LEU ALA GLU ALA ALA LYS ALA GLY THR SEQRES 18 B 401 ASP GLY ASN GLN VAL HIS LEU ALA LEU GLY SER GLY ALA SEQRES 19 B 401 SER VAL GLY LYS ASP GLY LEU LEU GLY ILE ARG SER GLU SEQRES 20 B 401 GLY LYS ARG SER THR THR ARG LEU LEU ASP ALA GLU PHE SEQRES 21 B 401 PRO LYS PHE ARG GLN LEU LEU PRO ALA GLU HIS THR ALA SEQRES 22 B 401 VAL ALA THR ILE GLY VAL ALA GLU LEU THR GLU ALA ILE SEQRES 23 B 401 LYS ARG VAL ALA LEU VAL ALA ASP ARG GLY ALA GLN ILE SEQRES 24 B 401 ARG MET GLU PHE SER ASP ASP THR LEU LYS LEU SER ALA SEQRES 25 B 401 GLY ALA ASP ASP VAL GLY ARG ALA GLU GLU ASP LEU PRO SEQRES 26 B 401 VAL ASP PHE ALA GLY GLU PRO LEU THR ILE ALA PHE ASN SEQRES 27 B 401 PRO THR TYR LEU THR ASP GLY LEU GLY SER LEU HIS SER SEQRES 28 B 401 GLU ARG VAL THR PHE GLY PHE THR THR PRO SER ARG PRO SEQRES 29 B 401 ALA VAL LEU ARG PRO ALA GLY GLU ASP ASP GLY ALA ASN SEQRES 30 B 401 GLY GLY SER GLY PRO PHE PRO ALA ALA LYS THR ASP TYR SEQRES 31 B 401 VAL TYR LEU LEU MET PRO VAL ARG LEU PRO GLY SEQRES 1 C 11 ACE MVA MP8 NZC LEU MP8 LEU MVA PH6 MLU GLY SEQRES 1 D 11 ACE MVA MP8 NZC LEU MP8 LEU MVA PH6 MLU GLY MODRES 5AH4 MVA C 2 VAL N-METHYLVALINE MODRES 5AH4 MP8 C 3 PRO (4R)-4-METHYL-L-PROLINE MODRES 5AH4 NZC C 4 THR N-METHYLIDENE-L-THREONINE MODRES 5AH4 MP8 C 6 PRO (4R)-4-METHYL-L-PROLINE MODRES 5AH4 MVA C 8 VAL N-METHYLVALINE MODRES 5AH4 PH6 C 9 PRO (4S)-4-CYCLOHEXYL-L-PROLINE MODRES 5AH4 MVA D 2 VAL N-METHYLVALINE MODRES 5AH4 MP8 D 3 PRO (4R)-4-METHYL-L-PROLINE MODRES 5AH4 NZC D 4 THR N-METHYLIDENE-L-THREONINE MODRES 5AH4 MP8 D 6 PRO (4R)-4-METHYL-L-PROLINE MODRES 5AH4 MVA D 8 VAL N-METHYLVALINE MODRES 5AH4 PH6 D 9 PRO (4S)-4-CYCLOHEXYL-L-PROLINE HET ACE C 1 3 HET MVA C 2 8 HET MP8 C 3 8 HET NZC C 4 8 HET MP8 C 6 8 HET MVA C 8 8 HET PH6 C 9 13 HET MLU C 10 9 HET ACE D 1 3 HET MVA D 2 8 HET MP8 D 3 8 HET NZC D 4 8 HET MP8 D 6 8 HET MVA D 8 8 HET PH6 D 9 13 HET MLU D 10 9 HET NA A1398 1 HETNAM ACE ACETYL GROUP HETNAM MVA N-METHYLVALINE HETNAM MP8 (4R)-4-METHYL-L-PROLINE HETNAM NZC N-METHYLIDENE-L-THREONINE HETNAM PH6 (4S)-4-CYCLOHEXYL-L-PROLINE HETNAM MLU N-METHYL-D-LEUCINE HETNAM NA SODIUM ION FORMUL 3 ACE 2(C2 H4 O) FORMUL 3 MVA 4(C6 H13 N O2) FORMUL 3 MP8 4(C6 H11 N O2) FORMUL 3 NZC 2(C5 H11 N O3) FORMUL 3 PH6 2(C11 H19 N O2) FORMUL 3 MLU 2(C7 H15 N O2) FORMUL 5 NA NA 1+ FORMUL 6 HOH *194(H2 O) HELIX 1 1 VAL A 16 SER A 30 1 15 HELIX 2 2 GLY A 81 LEU A 91 1 11 HELIX 3 3 ALA A 120 TYR A 124 5 5 HELIX 4 4 ALA A 138 VAL A 151 1 14 HELIX 5 5 LEU A 159 LEU A 162 5 4 HELIX 6 6 ALA A 206 ALA A 215 1 10 HELIX 7 7 PHE A 259 LEU A 263 5 5 HELIX 8 8 VAL A 275 ALA A 286 1 12 HELIX 9 9 LEU A 287 ALA A 293 5 7 HELIX 10 10 ASN A 334 LEU A 345 1 12 HELIX 11 11 VAL B 16 SER B 30 1 15 HELIX 12 12 ILE B 37 LEU B 40 5 4 HELIX 13 13 GLY B 81 ALA B 90 1 10 HELIX 14 14 SER B 139 VAL B 151 1 13 HELIX 15 15 LEU B 159 LEU B 162 5 4 HELIX 16 16 ALA B 206 GLY B 216 1 11 HELIX 17 17 PHE B 259 LEU B 263 5 5 HELIX 18 18 VAL B 275 LEU B 287 1 13 HELIX 19 19 VAL B 288 ALA B 293 5 6 HELIX 20 20 ASN B 334 GLY B 343 1 10 SHEET 1 AA 5 GLU A 70 SER A 73 0 SHEET 2 AA 5 LYS A 12 VAL A 15 -1 O LYS A 12 N ALA A 72 SHEET 3 AA 5 VAL A 96 GLU A 101 -1 O VAL A 96 N VAL A 15 SHEET 4 AA 5 ARG A 104 CYS A 109 -1 O ARG A 104 N GLU A 101 SHEET 5 AA 5 ALA A 112 PRO A 117 -1 O ALA A 112 N CYS A 109 SHEET 1 AB 9 GLY A 75 SER A 80 0 SHEET 2 AB 9 GLY A 42 GLY A 47 -1 O VAL A 43 N VAL A 79 SHEET 3 AB 9 LEU A 52 PHE A 57 -1 O THR A 53 N THR A 46 SHEET 4 AB 9 VAL A 61 VAL A 67 -1 O ALA A 63 N GLY A 56 SHEET 5 AB 9 LYS A 245 ARG A 250 -1 O ARG A 246 N GLU A 64 SHEET 6 AB 9 LEU A 237 SER A 242 -1 O LEU A 238 N THR A 249 SHEET 7 AB 9 VAL A 222 ALA A 225 -1 O HIS A 223 N ARG A 241 SHEET 8 AB 9 GLU A 133 ILE A 137 -1 N THR A 134 O LEU A 224 SHEET 9 AB 9 VAL A 192 THR A 193 -1 O VAL A 192 N VAL A 136 SHEET 1 AC 9 GLU A 199 PRO A 205 0 SHEET 2 AC 9 GLY A 164 SER A 170 -1 O ILE A 165 N VAL A 204 SHEET 3 AC 9 SER A 173 THR A 179 -1 O SER A 173 N SER A 170 SHEET 4 AC 9 ARG A 183 THR A 190 -1 O ALA A 185 N ALA A 178 SHEET 5 AC 9 TYR A 386 LEU A 390 -1 O VAL A 387 N VAL A 186 SHEET 6 AC 9 ALA A 361 PRO A 365 -1 O ALA A 361 N LEU A 390 SHEET 7 AC 9 ARG A 349 PHE A 354 -1 O THR A 351 N ARG A 364 SHEET 8 AC 9 ALA A 269 GLY A 274 -1 O ALA A 269 N PHE A 354 SHEET 9 AC 9 ASP A 323 GLY A 326 -1 O ASP A 323 N THR A 272 SHEET 1 AD 2 GLU A 266 HIS A 267 0 SHEET 2 AD 2 PHE A 379 PRO A 380 -1 O PHE A 379 N HIS A 267 SHEET 1 AE 4 GLY A 314 PRO A 321 0 SHEET 2 AE 4 THR A 303 ALA A 310 -1 O LEU A 304 N LEU A 320 SHEET 3 AE 4 ILE A 295 SER A 300 -1 O ARG A 296 N SER A 307 SHEET 4 AE 4 LEU A 329 PHE A 333 -1 O LEU A 329 N PHE A 299 SHEET 1 BA 5 GLU B 70 SER B 73 0 SHEET 2 BA 5 LYS B 12 VAL B 15 -1 O LYS B 12 N SER B 73 SHEET 3 BA 5 VAL B 96 GLU B 101 -1 O VAL B 96 N VAL B 15 SHEET 4 BA 5 ARG B 104 CYS B 109 -1 O ARG B 104 N GLU B 101 SHEET 5 BA 5 ALA B 112 PRO B 117 -1 O ALA B 112 N CYS B 109 SHEET 1 BB 9 GLY B 75 SER B 80 0 SHEET 2 BB 9 GLY B 42 GLY B 47 -1 O VAL B 43 N VAL B 79 SHEET 3 BB 9 LEU B 52 PHE B 57 -1 O THR B 53 N THR B 46 SHEET 4 BB 9 VAL B 61 VAL B 67 -1 O ALA B 63 N GLY B 56 SHEET 5 BB 9 LYS B 245 ARG B 250 -1 O ARG B 246 N GLU B 64 SHEET 6 BB 9 LEU B 237 SER B 242 -1 O LEU B 238 N THR B 249 SHEET 7 BB 9 GLN B 221 ALA B 225 -1 O HIS B 223 N ARG B 241 SHEET 8 BB 9 GLY B 135 ALA B 138 -1 O GLY B 135 N LEU B 224 SHEET 9 BB 9 VAL B 192 THR B 193 -1 O VAL B 192 N VAL B 136 SHEET 1 BC 9 GLU B 199 PRO B 205 0 SHEET 2 BC 9 GLY B 164 SER B 170 -1 O ILE B 165 N VAL B 204 SHEET 3 BC 9 SER B 173 THR B 179 -1 O SER B 173 N SER B 170 SHEET 4 BC 9 ARG B 183 THR B 190 -1 O ALA B 185 N ALA B 178 SHEET 5 BC 9 TYR B 386 LEU B 390 -1 O VAL B 387 N VAL B 186 SHEET 6 BC 9 ALA B 361 ALA B 366 -1 O ALA B 361 N LEU B 390 SHEET 7 BC 9 ARG B 349 PHE B 354 -1 O ARG B 349 N ALA B 366 SHEET 8 BC 9 ALA B 269 GLY B 274 -1 O ALA B 269 N PHE B 354 SHEET 9 BC 9 ASP B 323 GLY B 326 -1 O ASP B 323 N THR B 272 SHEET 1 BD 2 GLU B 266 HIS B 267 0 SHEET 2 BD 2 PHE B 379 PRO B 380 -1 O PHE B 379 N HIS B 267 SHEET 1 BE 4 GLY B 314 PRO B 321 0 SHEET 2 BE 4 THR B 303 ALA B 310 -1 O LEU B 304 N LEU B 320 SHEET 3 BE 4 ILE B 295 SER B 300 -1 O ARG B 296 N SER B 307 SHEET 4 BE 4 LEU B 329 PHE B 333 -1 O LEU B 329 N PHE B 299 LINK C ACE C 1 N MVA C 2 1555 1555 1.33 LINK C MVA C 2 N MP8 C 3 1555 1555 1.33 LINK C MP8 C 3 N NZC C 4 1555 1555 1.34 LINK C NZC C 4 N LEU C 5 1555 1555 1.33 LINK OG1 NZC C 4 C GLY C 11 1555 1555 1.44 LINK C LEU C 5 N MP8 C 6 1555 1555 1.34 LINK C MP8 C 6 N LEU C 7 1555 1555 1.32 LINK C LEU C 7 N MVA C 8 1555 1555 1.33 LINK C MVA C 8 N PH6 C 9 1555 1555 1.33 LINK C PH6 C 9 N MLU C 10 1555 1555 1.33 LINK C MLU C 10 N GLY C 11 1555 1555 1.34 LINK C ACE D 1 N MVA D 2 1555 1555 1.34 LINK C MVA D 2 N MP8 D 3 1555 1555 1.33 LINK C MP8 D 3 N NZC D 4 1555 1555 1.34 LINK C NZC D 4 N LEU D 5 1555 1555 1.34 LINK OG1 NZC D 4 C GLY D 11 1555 1555 1.44 LINK C LEU D 5 N MP8 D 6 1555 1555 1.33 LINK C MP8 D 6 N LEU D 7 1555 1555 1.34 LINK C LEU D 7 N MVA D 8 1555 1555 1.34 LINK C MVA D 8 N PH6 D 9 1555 1555 1.33 LINK C PH6 D 9 N MLU D 10 1555 1555 1.34 LINK C MLU D 10 N GLY D 11 1555 1555 1.34 LINK O GLU A 327 NA NA A1398 1555 1555 2.54 LINK O PRO A 328 NA NA A1398 1555 1555 3.17 LINK NA NA A1398 O HOH A2058 1555 1555 2.72 CISPEP 1 GLY A 377 PRO A 378 0 -0.20 CISPEP 2 GLY B 377 PRO B 378 0 0.75 CISPEP 3 MVA C 8 PH6 C 9 0 -3.58 CISPEP 4 MVA D 8 PH6 D 9 0 -1.99 SITE 1 AC1 4 GLU A 327 PRO A 328 LEU A 329 HOH A2058 SITE 1 AC2 18 ARG A 181 PHE A 182 ARG A 183 GLU A 255 SITE 2 AC2 18 PRO A 257 LYS A 258 LEU A 262 MET A 391 SITE 3 AC2 18 PRO A 392 VAL A 393 ARG A 394 HOH A2023 SITE 4 AC2 18 HOH A2087 HOH A2088 HOH A2091 HOH A2092 SITE 5 AC2 18 LEU B 159 MLU D 10 SITE 1 AC3 13 THR B 179 ARG B 181 PHE B 182 ARG B 183 SITE 2 AC3 13 GLU B 255 LYS B 258 LEU B 262 MET B 391 SITE 3 AC3 13 PRO B 392 ARG B 394 HOH B2101 HOH B2102 SITE 4 AC3 13 MLU C 10 CRYST1 151.888 96.124 92.272 90.00 124.41 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006584 0.000000 0.004510 0.00000 SCALE2 0.000000 0.010403 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013136 0.00000 MTRIX1 1 -0.986340 0.048070 0.157530 261.29227 1 MTRIX2 1 -0.047970 -0.998840 0.004470 -30.11184 1 MTRIX3 1 0.157560 -0.003150 0.987500 -20.46132 1